Roeker, Lindsey E. http://orcid.org/0000-0002-3806-059X
Knorr, David A. http://orcid.org/0000-0002-0766-8914
Pessin, Melissa S. http://orcid.org/0000-0003-3990-6494
Ramanathan, Lakshmi V.
Thompson, Meghan C.
Leslie, Lori A.
Zelenetz, Andrew D.
Mato, Anthony R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 27 July 2020
Revised: 1 August 2020
Accepted: 12 August 2020
First Online: 27 August 2020
Compliance with ethical standards
:
: ER has received grant funding from American Society of Hematology outside of the submitted work and has minority ownership interest in AbbVie and Abbott Laboratories; LVR has received institutional research funding outside of submitted work from Abbott, IBM, and BioPortal; LAL is a member of speaker’s bureau for Seattle Genetics, Celgene/BMS, KitePharma, BeiGene, Pharmacyclics/Janssen, AstraZeneca, Epizyme, Karyopharm, advisory board participant for Bayer, Seattle genetics, ADC therapeutics, Abbvie, Janssen, Pharmacyclics, Kite, AstraZeneca, TG Therapeutics; ADZ has received research grants from Abbvie, Adaptive Biotechnologies, BMS, BeiGene, Genentech/Roche, MEI Pharma, consulting fees from Amgen, AstraZeneca, BeiGene, Genentech/Roche, Janssen, JUNO/Celgene/BMS, Kite/Gilead, MEI Pharma, Pfizer, Pharmacyclics, Sandoz/Novartis, and serves on the scientific advisory board of Adaptive Biotechnologies, Lymphoma Research Foundation; ARM has received grants, personal fees and other from TG Therapeutics, grants and personal fees from Pharmacyclics, grants and personal fees from Janssen, grants and other from Celgene, grants and personal fees from Genentch, grants and personal fees from Abbvie, grants and personal fees from Adaptive, grants from Loxo, grants from Sunesis, grants from Regeneron, grants from DTRM, personal fees from Beigene, grants and personal fees from AstraZenica.
Free to read: This content has been made available to all.